Skip to main content
. 2020 May 6;105(7):e2378–e2388. doi: 10.1210/clinem/dgaa241

Table 1.

Baseline characteristics of the subjects

Protocol 1 (Cortisol) Protocol 2 (Glucagon)
Subject Characteristics No Diabetes (N = 17) Type 2 Diabetes (N = 17) No Diabetes (N = 21) Type 2 Diabetes (N = 18)
Age (years) 61 ± 14 62 ± 20 58 ± 8 59 ± 12
Gender (M:F) 9:8 9:8 11:10 11:7
Body mass index (kg/m2) 30 ± 2 31 ± 3 29 ± 3 31 ± 3
Fat Free Mass (kg) 55 ± 11 53 ± 9 54 ± 10 56 ± 10
HbA1c (%) mmol/mol 5.3 ± 0.2/36 ± 2 7.6 ± 1.0/59 ± 12* 5.3 ± 0.4/34 ± 4 7.2 ± 0.7/56 ± 8*
Fasting plasma glucose (mg/dL) 90 ± 5 161 ± 49* 94 ± 8 146 ± 38*

Data are mean ± standard deviation.

*P < 0.001 vs ND